Quantinno Capital Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Quantinno Capital Management's DFTX Position: Q3 2026 in Review
Quantinno Capital Management reduced its Definium Therapeutics (DFTX) stake by 3% in Q3 2026, selling an estimated $89.9K and leaving 68,549 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1969.
Quantinno Capital Management first reported a position in DFTX in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.32M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Quantinno Capital Management held 68,549 shares of Definium Therapeutics worth $2.61M as of Q3 2026.
- Quantinno Capital Management sold 2,133 Definium Therapeutics shares in Q3 2026, an estimated $89.9K.
- Definium Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1969 holding.
- Quantinno Capital Management first reported a position in Definium Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Quantinno Capital Management's Definium Therapeutics position peaked at $3.32M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.